Neuronetics (STIM) Amortization of Deferred Charges (2017 - 2026)
Neuronetics' (STIM) quarterly Amortization of Deferred Charges came in at $256000.0 in Q1 2026, up 35.45% year-on-year from $189000.0 in Q1 2025, and up 14.29% on a QoQ basis from $224000.0 in Q4 2025.
Neuronetics (STIM) Amortization of Deferred Charges (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Amortization of Deferred Charges data on file, last reported at $256000.0 in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 35.45% year-over-year to $256000.0 in Q1 2026; TTM through Mar 2026 was $880000.0, a 15.79% increase from a year earlier, with the FY2025 full-year figure at $824000.0, up 6.87% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $256000.0, up from $224000.0 in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for STIM reached as high as $300000.0 in Q2 2024 and fell as low as $100000.0 in Q2 2023.
- Historically, Amortization of Deferred Charges has averaged $179588.2 across 5 years, with a median of $189000.0 in 2025.
- Across the five-year window, Amortization of Deferred Charges slumped 50.0% in 2023 and surged 200.0% in 2024, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $200000.0 in 2022, then slumped by 50.0% to $100000.0 in 2023, then jumped by 71.0% to $171000.0 in 2024, then surged by 30.99% to $224000.0 in 2025, then gained by 14.29% to $256000.0 in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $256000.0 in Q1 2026, $224000.0 in Q4 2025, and $200000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn |
| 10 | Neuronetics | 124.56 Mn | 118.56 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 256,000.00 |
| Mar 31, 2026 | 256,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Dec 31, 2025 | 224,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 189,000.00 |
| Mar 31, 2025 | 189,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Dec 31, 2024 | 171,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Mar 31, 2024 | 161,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |